Qinggan Lidan Granule
Function and Efficacy
This product can significantly inhibit the increase of serum PT, OT, and T-BI in rats caused by acute liver injury caused by CC4, increase the albumin content, decrease the globulin content, and increase the albumin/globulin ratio, which can reduce the liver tissue damage caused by CC4, and can significantly reduce the increase of serum PT in chronic liver injury caused by CC4, increase the albumin/globulin ratio, and reduce the turbidity and fatty changes of liver tissue caused by CC4, and has a tendency to promote bile secretion in rats and the phagocytic function of the reticuloendothelial system in mice.
Ingredients
Artemisia capillaris, Lysimachia chinensis, Gardenia jasminoides, Magnolia officinalis, Stephania tetrandra.
Appearance
This product is yellow-brown to brown granules; bitter in taste.
Usage and Dosage
Oral administration: 2-3 bags at a time, twice a day; 10 days is a course of treatment.
Adverse Reactions
Not yet clear.
Precautions
Not yet clear.
Drug Interactions
Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.
Storage
seal.
Packaging Specification
2g per bag
Validity Period
24 months
Manufacturer
Jiangxi Kang'enbei Tianshikang Pharmaceutical Co., Ltd.
-
Founded in:
2002-12-31 -
Address:
North of National Highway 320, Jiaotong North Road, Yujiang District, Yingtan City, Jiangxi Province -
Tax NO.:
913606007460554892 -
Registered Funds:
280 million yuan -
Website:
-
Email: